Crinetics Pharmaceuticals, Inc. (CRNX)
38.90
-0.61
(-1.54%)
USD |
NASDAQ |
Mar 05, 16:00
38.88
-0.02
(-0.05%)
After-Hours: 20:00
Crinetics Pharmaceuticals Research and Development Expense (Annual) : 328.17M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Plus Therapeutics, Inc. | 10.58M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| GT Biopharma, Inc. | 3.472M |
| Axsome Therapeutics, Inc. | 182.78M |
| Sutro Biopharma, Inc. | 252.04M |